CollPlant Biotechnologies (CLGN) Competitors $1.98 0.00 (0.00%) Closing price 05/21/2025 03:12 PM EasternExtended Trading$2.00 +0.02 (+1.26%) As of 05/21/2025 06:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLGN vs. SRTS, INO, ZYXI, OM, EDAP, NSPR, BSGM, VANI, CTCX, and NTRBShould you be buying CollPlant Biotechnologies stock or one of its competitors? The main competitors of CollPlant Biotechnologies include Sensus Healthcare (SRTS), Inovio Pharmaceuticals (INO), Zynex (ZYXI), Outset Medical (OM), Edap Tms (EDAP), InspireMD (NSPR), BioSig Technologies (BSGM), Vivani Medical (VANI), Carmell (CTCX), and Nutriband (NTRB). These companies are all part of the "medical equipment" industry. CollPlant Biotechnologies vs. Sensus Healthcare Inovio Pharmaceuticals Zynex Outset Medical Edap Tms InspireMD BioSig Technologies Vivani Medical Carmell Nutriband Sensus Healthcare (NASDAQ:SRTS) and CollPlant Biotechnologies (NASDAQ:CLGN) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, media sentiment, profitability, valuation, earnings, risk, institutional ownership and community ranking. Which has more volatility and risk, SRTS or CLGN? Sensus Healthcare has a beta of 1.3, meaning that its stock price is 30% more volatile than the S&P 500. Comparatively, CollPlant Biotechnologies has a beta of 1.24, meaning that its stock price is 24% more volatile than the S&P 500. Do institutionals and insiders hold more shares of SRTS or CLGN? 25.3% of Sensus Healthcare shares are owned by institutional investors. Comparatively, 21.7% of CollPlant Biotechnologies shares are owned by institutional investors. 8.9% of Sensus Healthcare shares are owned by company insiders. Comparatively, 9.6% of CollPlant Biotechnologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Do analysts rate SRTS or CLGN? Sensus Healthcare presently has a consensus target price of $11.67, suggesting a potential upside of 147.70%. CollPlant Biotechnologies has a consensus target price of $12.50, suggesting a potential upside of 531.31%. Given CollPlant Biotechnologies' stronger consensus rating and higher possible upside, analysts clearly believe CollPlant Biotechnologies is more favorable than Sensus Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensus Healthcare 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25CollPlant Biotechnologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Does the media prefer SRTS or CLGN? In the previous week, Sensus Healthcare had 18 more articles in the media than CollPlant Biotechnologies. MarketBeat recorded 18 mentions for Sensus Healthcare and 0 mentions for CollPlant Biotechnologies. Sensus Healthcare's average media sentiment score of 0.10 beat CollPlant Biotechnologies' score of 0.00 indicating that Sensus Healthcare is being referred to more favorably in the media. Company Overall Sentiment Sensus Healthcare Neutral CollPlant Biotechnologies Neutral Does the MarketBeat Community believe in SRTS or CLGN? Sensus Healthcare received 46 more outperform votes than CollPlant Biotechnologies when rated by MarketBeat users. Likewise, 69.00% of users gave Sensus Healthcare an outperform vote while only 60.00% of users gave CollPlant Biotechnologies an outperform vote. CompanyUnderperformOutperformSensus HealthcareOutperform Votes18769.00% Underperform Votes8431.00% CollPlant BiotechnologiesOutperform Votes14160.00% Underperform Votes9440.00% Which has higher earnings & valuation, SRTS or CLGN? Sensus Healthcare has higher revenue and earnings than CollPlant Biotechnologies. CollPlant Biotechnologies is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSensus Healthcare$41.81M1.86$6.65M$0.1047.10CollPlant Biotechnologies$515K44.04-$7.02M-$1.46-1.36 Is SRTS or CLGN more profitable? Sensus Healthcare has a net margin of 15.90% compared to CollPlant Biotechnologies' net margin of -2,680.00%. Sensus Healthcare's return on equity of 12.60% beat CollPlant Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets Sensus Healthcare15.90% 12.60% 11.38% CollPlant Biotechnologies -2,680.00%-77.05%-61.43% SummarySensus Healthcare beats CollPlant Biotechnologies on 14 of the 18 factors compared between the two stocks. Get CollPlant Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for CLGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLGN vs. The Competition Export to ExcelMetricCollPlant BiotechnologiesSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$22.68M$9.51B$5.35B$8.38BDividend YieldN/A1.61%5.22%4.10%P/E Ratio-1.2920.8726.8419.71Price / Sales44.0463.84391.39116.98Price / CashN/A19.6738.2534.62Price / Book0.805.056.794.50Net Income-$7.02M$284.66M$3.23B$248.18M7 Day Performance21.10%-1.23%4.07%1.14%1 Month Performance-15.74%4.43%12.52%15.20%1 Year Performance-67.54%-21.30%16.83%6.56% CollPlant Biotechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLGNCollPlant Biotechnologies2.5439 of 5 stars$1.98flat$12.50+531.3%-67.5%$22.68M$515,000.00-1.2970Upcoming EarningsSRTSSensus Healthcare2.7091 of 5 stars$4.73+6.1%$11.67+146.7%-20.7%$78.02M$41.81M11.8340News CoverageEarnings ReportAnalyst ForecastAnalyst RevisionINOInovio Pharmaceuticals3.6587 of 5 stars$2.07+1.0%$9.75+371.0%-82.0%$75.92M$217,756.00-0.65320ZYXIZynex3.0227 of 5 stars$2.36-4.8%$6.00+154.2%-78.5%$74.99M$172.40M15.73770Gap DownOMOutset Medical1.2398 of 5 stars$19.58+0.4%$24.67+26.0%-66.3%$70.39M$115.27M-7.90520Analyst ForecastGap DownHigh Trading VolumeEDAPEdap Tms1.8227 of 5 stars$1.86+5.7%$8.50+357.0%-71.0%$69.55M$64.12M-2.86230Earnings ReportAnalyst RevisionGap DownNSPRInspireMD2.2409 of 5 stars$2.26-4.2%$4.50+99.1%-4.7%$69.24M$7.03M-3.0150Gap UpBSGMBioSig Technologies0.3674 of 5 stars$2.85+9.2%$2.50-12.3%+79.3%$69.12M$40,000.000.0050Earnings ReportGap UpVANIVivani Medical3.1245 of 5 stars$1.07+3.9%$4.00+273.8%-36.7%$63.39MN/A-2.3820News CoverageAnalyst ForecastCTCXCarmellN/A$3.00-2.8%N/A+35.8%$62.72M$32,839.000.0014NTRBNutriband2.1833 of 5 stars$5.71+1.6%$13.00+127.7%+9.2%$62.69M$2.14M-8.0410Positive News Related Companies and Tools Related Companies Sensus Healthcare Competitors Inovio Pharmaceuticals Competitors Zynex Competitors Outset Medical Competitors Edap Tms Competitors InspireMD Competitors BioSig Technologies Competitors Vivani Medical Competitors Carmell Competitors Nutriband Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLGN) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CollPlant Biotechnologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share CollPlant Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CLGN Stock Free CLGN Stock Alerts